Document:

Exhibit 10.3

                         EQUITY LINE OF CREDIT AGREEMENT
                         -------------------------------

         AGREEMENT dated as of the 25th day of July 2002 (the "Agreement")
between CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the
"Investor"), and BIO-ONE CORPORATION, a corporation organized and existing under
the laws of the State of Nevada (the "Company").

         WHEREAS, the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell to the Investor,
from time to time as provided herein, and the Investor shall purchase from the
Company up to Ten Million ($10,000,000) Dollars of the Company's common stock,
par value $.001 per share (the "Common Stock"); and

         WHEREAS, such investments will be made in reliance upon the provisions
of Regulation D ("Regulation D") of the Securities Act of 1933, as amended, and
the regulations promulgated there under (the "Securities Act"), and or upon such
other exemption from the registration requirements of the Securities Act as may
be available with respect to any or all of the investments to be made hereunder.

         WHEREAS, the Company has engaged Westrock Advisors, Inc. to act as the
Company's exclusive placement agent in connection with the sale of the Company's
Common Stock to the Investor hereunder.

         NOW, THEREFORE, the parties hereto agree as follows:

                                   ARTICLE I.
                               CERTAIN DEFINITIONS

         Section 1.1 "Advance" shall mean the portion of the Commitment Amount
requested by the Company in the Advance Notice.

         Section 1.2 "Advance Date" shall mean the date Butler Gonzalez
LLP/Wachovia Bank, N.A. Escrow Account is in receipt of the funds from the
Investor and Butler Gonzalez LLP, as the Investor' s Counsel, is in possession
of free trading shares from the Company and therefore an Advance by the Investor
to the Company can be made and Butler Gonzalez LLP can release the free trading
shares to the Investor. No Advance Date shall be less than six (6) Trading Days
after an Advance Notice Date.

         Section 1.3 "Advance Notice" shall mean a written notice to the
Investor setting forth the Advance amount that the Company requests from the
Investor and the Advance Date.

<PAGE>

         Section 1.4 "Advance Notice Date" shall mean each date the Company
delivers to the Investor an Advance Notice requiring the Investor to advance
funds to the Company, subject to the terms of this Agreement. No Advance Notice
Date shall be less than seven (7) Trading Days after the prior Advance Notice
Date.

         Section 1.5 "Bid Price" shall mean, on any date, the closing bid price
(as reported by Bloomberg L.P.) of the Common Stock on the Principal Market or
if the Common Stock is not traded on a Principal Market, the highest reported
bid price for the Common Stock, as furnished by the National Association of
Securities Dealers, Inc.

         Section 1.6 "Closing" shall mean one of the closings of a purchase and
sale of Common Stock pursuant to Section 2.3.

         Section 1.7 "Commitment Amount" shall mean the aggregate amount of up
to Ten Million Dollars ($10,000,000) which the Investor has agreed to provide to
the Company in order to purchase the Company's Common Stock pursuant to the
terms and conditions of this Agreement.

         Section 1.8 "Commitment Period" shall mean the period commencing on the
earlier to occur of (i) the Effective Date, or (ii) such earlier date as the
Company and the Investor may mutually agree in writing, and expiring on the
earliest to occur of (x) the date on which the Investor shall have made payment
of Advances pursuant to this Agreement in the aggregate amount of Ten Million
Dollars ($10,000,000), (y) the date this Agreement is terminated pursuant to
Section 2.5, or (z) the date occurring twenty-four (24) months after the
Effective Date.

         Section 1.9 "Common Stock" shall mean the Company's common stock, par
value $.001 per share.

         Section 1.10 "Condition Satisfaction Date" shall have the meaning set
forth in Section 7.2.

         Section 1.11 "Damages" shall mean any loss, claim, damage, liability,
costs and expenses (including, without limitation, reasonable attorney's fees
and disbursements and costs and expenses of expert witnesses and investigation).

         Section 1.12 "Effective Date " shall mean the date on which the SEC
first declares effective a Registration Statement registering the resale of the
Registrable Securities as set forth in Section 7.2(a).

         Section 1.13 "Escrow Agreement" shall mean the escrow agreement among
the Company, the Investor, the Investor's Counsel and Wachovia, N.A. dated the
date hereof.

         Section 1.14 "Exchange Act" shall mean the Securities and Exchange Act
of 1934, as amended, and the rules and regulations promulgated there under.

         Section 1.15 "Material Adverse Effect" shall mean any condition,
circumstance, or situation that would prohibit or otherwise materially interfere
with the ability of the Company to enter into and perform any of its obligations
under this Agreement or the Registration Rights Agreement in any material
respect.

                                       2
<PAGE>

         Section 1.16 "Market Price" shall mean the lowest closing Bid Price of
the Common Stock during the Pricing Period.

         Section 1.17 "Maximum Advance Amount" shall be equal up to One Hundred
Seventy Five Thousand Dollars ($175,000) per
Advance Notice.

            Section 1.18 "Minimum Acceptable Price"shall mean a price of the
Company's Common Stock as determined by the Company on the Advance Notice Date
of which the Investor shall be advised of in writing simultaneously with the
Advance Notice.

         Section 1.19 "NASD" shall mean the National Association of Securities
Dealers, Inc.

         Section 1.20 "Person" shall mean an individual, a corporation, a
partnership, an association, a trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality thereof.

         Section 1.21 "Placement Agent" shall mean Westrock Advisors, Inc. a
registered broker-dealer.

         Section 1.22 "Pricing Period" shall mean the five (5) consecutive
Trading Days after the Advance Notice Date.

         Section 1.23 "Principal Market" shall mean the Nasdaq National Market,
the Nasdaq SmallCap Market, the American Stock Exchange, the OTC Bulletin Board
or the New York Stock Exchange, whichever is at the time the principal trading
exchange or market for the Common Stock.

         Section 1.24 "Purchase Price" shall be set at one hundred percent
(100%) of the Market Price during the Pricing Period.

         Section 1.25 "Registrable Securities" shall mean the shares of Common
Stock (i) in respect of which the Registration Statement has not been declared
effective by the SEC, (ii) which have not been sold under circumstances meeting
all of the applicable conditions of Rule 144 (or any similar provision then in
force) under the Securities Act ("Rule 144") or (iii) which have not been
otherwise transferred to a holder who may trade such shares without restriction
under the Securities Act, and the Company has delivered a new certificate or
other evidence of ownership for such securities not bearing a restrictive
legend.

         Section 1.26 "Registration Rights Agreement" shall mean the
Registration Rights Agreement dated the date hereof, regarding the filing of the
Registration Statement for the resale of the Registrable Securities, entered
into between the Company and the Investor.

         Section 1.27 "Registration Statement" shall mean a registration
statement on Form S-1 or SB-2 (if use of such form is then available to the
Company pursuant to the rules of the SEC and, if not, on such other form
promulgated by the SEC for which the Company then qualifies and which counsel
for the Company shall deem appropriate, and which form shall be available for
the resale of the Registrable Securities to be registered there under in
accordance with the provisions of this Agreement and the Registration Rights
Agreement, and in accordance with the intended method of distribution of such
securities), for the registration of the resale by the Investor of the
Registrable Securities under the Securities Act.

                                       3
<PAGE>

         Section 1.28 "Regulation D" shall have the meaning set forth in the
recitals of this Agreement.

         Section 1.29 "SEC" shall mean the Securities and Exchange Commission.

         Section 1.30 "Securities Act" shall have the meaning set forth in the
recitals of this Agreement.

         Section 1.31 "SEC Documents" shall mean Annual Reports on Form 10-KSB,
Quarterly Reports on Form 10-QSB, Current Reports on Form 8-K and Proxy
Statements of the Company as supplemented to the date hereof, filed by the
Company for a period of at least twelve (12) months immediately preceding the
date hereof or the Advance Date, as the case may be, until such time as the
Company no longer has an obligation to maintain the effectiveness of a
Registration Statement as set forth in the Registration Rights Agreement.

         Section 1.32 "Trading Day" shall mean any day during which the New York
Stock Exchange shall be open for business.

                                   ARTICLE II.
                                    ADVANCES

         Section 2.1 Investments.

                  (a) Advances. Upon the terms and conditions set forth herein
(including, without limitation, the provisions of Article VII hereof), on any
Advance Notice Date the Company may request an Advance by the Investor by the
delivery of an Advance Notice. The number of shares of Common Stock that the
Investor shall receive for each Advance shall be determined by dividing the
amount of the Advance by the Purchase Price. No fractional shares shall be
issued. Fractional shares shall be rounded to the next higher whole number of
shares. The aggregate maximum amount of all Advances that the Investor shall be
obligated to make under this Agreement shall not exceed the Commitment Amount.

                  (b) Notwithstanding the foregoing the Company shall only be
entitled to an Advance if the Company's Common Stock has an active bid at all
times during the Pricing Period.

                  (c) The Company acknowledges that the Investor may sell the
Company's Common Stock purchased pursuant to an Advance Notice during the
corresponding Pricing Period.

         Section 2.2 Mechanics.

                  (a) Advance Notice. At any time during the Commitment Period,
the Company may deliver an Advance Notice to the Investor, subject to the
conditions set forth in Section 7.2; provided, however, unless waived by the
Investor, the amount for each Advance as designated by the Company in the
applicable Advance Notice, shall not be more than the Maximum Advance Amount.
The aggregate amount of the Advances pursuant to this Agreement shall not exceed

                                       4
<PAGE>

the Commitment Amount, unless otherwise agreed by the Investor in the Investor's
sole and absolute discretion. The Company acknowledges that the Investor may
sell shares of the Company's Common Stock corresponding with a particular
Advance Notice on the day the Advance Notice is received by the Investor. There
will be a minimum of seven (7) Trading Days between each Advance Notice Date.

                  (b) Withdrawal of Advance Notice. The Company shall
automatically withdraw a pro rata portion of the Advance Notice amount based on
the number of days the closing bid price of the Company's Common Stock (as
reported by Bloomberg, L.P.) during the Pricing Period is lower than the Minimum
Acceptable Price. The shares of Common Stock issued shall also be reduced to
correspond with the reduction in the Advance Notice amount. For example, if the
closing bid price of the Company's Common Stock on the Advance Notice Date is
$0.26, and the Minimum Acceptable Price as determined by the Company is $0.16.
For every day during the Pricing Period that the closing bid price of the
Company's Common Stock is below $0.16 the Advance Notice amount shall be reduced
by Twenty Percent (20%). If the Advance Notice amount is One Hundred Seventy
Five Thousand Dollars ($175,000) and the closing bid price of the Company's
Common Stock is below the Minimum Acceptable Price for two (2) of the five (5)
days of the Pricing Period, the Purchase Amount shall be reduced by 40% (2 x
20%) or Seventy Thousand Dollars ($70,000) (40% of $175,000 = $70,000) and
therefore the reduced Advance Notice amount shall be One Hundred Five Thousand
Dollars ($105,000) (the "Reduced Advance Notice amount") ($175,000-$70,000 =
$105,000). Accordingly the number of shares of Common Stock issued to the
Investor shall be reduced and calculated by dividing the Reduced Advance Notice
amount by the Purchase Price.

                  (c) Date of Delivery of Advance Notice. An Advance Notice
shall be deemed delivered on (i) the Trading Day it is received by facsimile or
otherwise by the Investor if such notice is received prior to 12:00 noon Eastern
Time, or (ii) the immediately succeeding Trading Day if it is received by
facsimile or otherwise after 12:00 noon Eastern Time on a Trading Day or at any
time on a day which is not a Trading Day. No Advance Notice may be deemed
delivered, on a day that is not a Trading Day.

                  (d) Pre-Closing Share Credit. Within two (2) business days
after the Advance Notice Date, the Company shall credit shares of the Company's
Common Stock to the Investor's balance account with The Depository Trust Company
through its Deposit Withdrawal At Custodian system, in an amount equal to the
amount of the requested Advance divided by the closing Bid Price of the
Company's Common Stock as of the Advance Notice Date multiplied by one point one
(1.1). Any adjustments to the number of shares to be delivered to the Investor
at the Closing as a result of fluctuations in the closing Bid Price of the
Company's Common Stock shall be made as of the date of the Closing. Any excess
shares shall be credited to the next Advance. In no event shall the number of
shares issuable to the Investor pursuant to an Advance cause the Investor to own
in excess of nine and 9/10 percent (9.9%) of the then outstanding Common Stock
of the Company.

                  (e) Hardship. In the event the Investor sells the Company's
Common Stock pursuant to subsection (c) above and the Company fails to perform
its obligations as mandated in Section 2.5 and 2.2 (c), and specifically fails
to provide the Investor with the shares of Common Stock for the applicable
Advance, the Company acknowledges that the Investor shall suffer financial
hardship and therefore shall be liable for any and all losses, commissions,
fees, or financial hardship caused to the Investor.

                                       5
<PAGE>

         Section 2.3 Closings. On each Advance Date, which shall be six (6)
Trading Days after an Advance Notice Date, (i) the Company shall deliver to the
Investor 's Counsel, as defined pursuant to the Escrow Agreement, shares of the
Company's Common Stock, representing the amount of the Advance by the Investor
pursuant to Section 2.1 herein, registered in the name of the Investor which
shall be delivered to the Investor, or otherwise in accordance with the Escrow
Agreement and (ii) the Investor shall deliver to Wachovia Bank, N.A. (the
"Escrow Agent") the amount of the Advance specified in the Advance Notice by
wire transfer of immediately available funds which shall be delivered to the
Company, or otherwise in accordance with the Escrow Agreement. In addition, on
or prior to the Advance Date, each of the Company and the Investor shall deliver
to the other through the Investor's Counsel all documents, instruments and
writings required to be delivered or reasonably requested by either of them
pursuant to this Agreement in order to implement and effect the transactions
contemplated herein. Payment of funds to the Company and delivery of the
Company's Common Stock to the Investor shall occur in accordance with the
conditions set forth above and those contai ned in the Escrow Agreement;
provided, however, that to the extent the Company has not paid the fees,
expenses, and disbursements of the Investor, the Investor's counsel in
accordance with Section 12.4, the amount of such fees, expenses, and
disbursements may be deducted by the Investor (and shall be paid to the relevant
party) from the amount of the Advance with no reduction in the amount of shares
of the Company's Common Stock to be delivered on such Advance Date.

         Section 2.4 Termination of Investment. The obligation of the Investor
to make an Advance to the Company pursuant to this Agreement shall terminate
permanently (including with respect to an Advance Date that has not yet
occurred) in the event that (i) there shall occur any stop order or suspension
of the effectiveness of the Registration Statement for an aggregate of fifty
(50) Trading Days, other than due to the acts of the Investor, during the
Commitment Period, and (ii) the Company shall at any time fail materially to
comply with the requirements of Article VI and such failure is not cured within
thirty (30) days after receipt of written notice from the Investor, provided,
however, that this termination provision shall not apply to any period
commencing upon the filing of a post-effective amendment to such Registration
Statement and ending upon the date on which such post effective amendment is
declared effective by the SEC.

         Section 2.5 Agreement to Advance Funds.

                  (a) The Investor agrees to advance the amount specified in the
Advance Notice to the Company after the completion of each of the following
conditions and the other conditions set forth in this Agreement:

                           (i) the execution and delivery by the Company, and
the Investor, of this Agreement, and the Exhibits
hereto;

                           (ii) Investor's Counsel shall have received the
shares of Common Stock applicable to the Advance in
accordance with Section 2.2(c) hereof;

                                       6
<PAGE>

                           (iii) the Company's Registration Statement with
respect to the resale of the Registrable Securities in accordance with the terms
of the Registration Rights Agreement shall have been declared effective by the
SEC;

                           (iv) the Company shall have obtained all material
permits and qualifications required by any applicable state for the offer and
sale of the Registrable Securities, or shall have the availability of exemptions
there from. The sale and issuance of the Registrable Securities shall be legally
permitted by all laws and regulations to which the Company is subject;

                           (v) the Company shall have filed with the Commission
in a timely manner all reports, notices and other documents required of a
"reporting company" under the Exchange Act and applicable Commission
regulations;

                           (vi) the fees as set forth in Section 12.4 below
shall have been paid or can be withheld as provided in Section 2.3; and

                           (vii) the conditions set forth in Section 7.2 shall
have been satisfied.

                           (viii) The Company shall have provided to the
Investor an acknowledgement, to the satisfaction of the Investor, from Parks,
Tschopp, Whitcomb & Orr, P.A., the Company's accountant, as to the accountant's
ability to provide all consents required in order to file a registration
statement in connection with this transaction;

                           (ix) The Company's transfer agent shall be DWAC
eligible.

         Section 2.6 Lock Up Period.

                           (i) The Company shall not, without the prior consent
of the Investor, issue or sell (i) any Common Stock without consideration or for
a consideration per share less than the Bid Price on the date of issuance or
(ii) issue or sell any warrant, option, right, contract, call, or other security
or instrument granting the holder thereof the right to acquire Common Stock
without consideration or for a consideration per share less than the Bid Price
on the date of issuance.

                           (ii) On the date hereof, the Company shall obtain
from each officer and director a lock-up agreement, as defined below, in the
form annexed hereto as Schedule 2.6(b) agreeing to only sell in compliance with
the volume limitation of Rule 144.

                                  ARTICLE III.
                   REPRESENTATIONS AND WARRANTIES OF INVESTOR

         Investor hereby represents and warrants to, and agrees with, the
Company that the following are true and as of the date hereof and as of each
Advance Date:

         Section 3.1 Organization and Authorization. The Investor is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority to
purchase and hold the securities issuable hereunder. The decision to invest and
the execution and delivery of this Agreement by such Investor, the performance

                                       7
<PAGE>

by such Investor of its obligations hereunder and the consummation by such
Investor of the transactions contemplated hereby have been duly authorized and
requires no other proceedings on the part of the Investor. The undersigned has
the right, power and authority to execute and deliver this Agreement and all
other instruments (including, without limitations, the Registration Rights
Agreement), on behalf of the Investor. This Agreement has been duly executed and
delivered by the Investor and, assuming the execution and delivery hereof and
acceptance thereof by the Company, will constitute the legal, valid and binding
obligations of the Investor, enforceable against the Investor in accordance with
its terms.

         Section 3.2 Evaluation of Risks. The Investor has such knowledge and
experience in financial tax and business matters as to be capable of evaluating
the merits and risks of, and bearing the economic risks entailed by, an
investment in the Company and of protecting its interests in connection with
this transaction. It recognizes that its investment in the Company involves a
high degree of risk.

         Section 3.3 No Legal Advice From the Company. The Investor acknowledges
that it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with his or its own legal counsel and investment
and tax advisors. The Investor is relying solely on such counsel and advisors
and not on any statements or representations of the Company or any of its
representatives or agents for legal, tax or investment advice with respect to
this investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.

         Section 3.4 Investment Purpose. The securities are being purchased by
the Investor for its own account, for investment and without any view to the
distribution, assignment or resale to others or fractionalization in whole or in
part. The Investor agrees not to assign or in any way transfer the Investor's
rights to the securities or any interest therein and acknowledges that the
Company will not recognize any purported assignment or transfer except in
accordance with applicable Federal and state securities laws. No other person
has or will have a direct or indirect beneficial interest in the securities. The
Investor agrees not to sell, hypothecate or otherwise transfer the Investor's
securities unless the securities are registered under Federal and applicable
state securities laws or unless, in the opinion of counsel satisfactory to the
Company, an exemption from such laws is available.

         Section 3.5 Accredited Investor. Investor is an "Accredited Investor"
as that term is defined in Rule 501(a)(3) of Regulation D of the Securities Act.

         Section 3.6 Information. The Investor and its advisors (and its
counsel), if any, have been furnished with all materials relating to the
business, finances and operations of the Company and information it deemed
material to making an informed investment decision. The Investor and its
advisors, if any, have been afforded the opportunity to ask questions of the
Company and its management. Neither such inquiries nor any other due diligence
investigations conducted by such Investor or its advisors, if any, or its
representatives shall modify, amend or affect the Investor's right to rely on
the Company's representations and warranties contained in this Agreement. The
Investor understands that its investment involves a high degree of risk. The
Investor is in a position regarding the Company, which, based upon employment,
family relationship or economic bargaining power, enabled and enables such
Investor to obtain information from the Company in order to evaluate the merits
and risks of this investment. The Investor has sought such accounting, legal and
tax advice, as it has considered necessary to make an informed investment
decision with respect to this transaction.

                                       8
<PAGE>

         Section 3.7 Receipt of Documents. The Investor and its counsel has
received and read in their entirety: (i) this Agreement and the Exhibits annexed
hereto; (ii) all due diligence and other information necessary to verify the
accuracy and completeness of such representations, warranties and covenants;
(iii) the Company's Form 10-KSB for the year ended December 31, 2001 and Form
10-QSB for the period ended March 31, 2002; and (iv) answers to all questions
the Investor submitted to the Company regarding an investment in the Company;
and the Investor has relied on the information contained therein and has not
been furnished any other documents, literature, memorandum or prospectus.

         Section 3.8 Registration Rights Agreement and Escrow Agreement. The
parties have entered into the Registration Rights Agreement and the Escrow
Agreement, each dated the date hereof.

         Section 3.9 No General Solicitation. Neither the Company, nor any of
its affiliates, nor any person acting on its or their behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of
Regulation D under the Securities Act) in connection with the offer or sale of
the shares of Common Stock offered hereby.

         Section 3.10 Not an Affiliate. The Investor is not an officer, director
or a person that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under common control with the Company or any
"Affiliate" of the Company (as that term is defined in Rule 405 of the
Securities Act). Neither the Investor nor its Affiliates has an open short
position in the Common Stock of the Company, and the Investor agrees that it
will not, and that it will cause its Affiliates not to, engage in any short
sales of or hedging transactions with respect to the Common Stock, provided that
the Company acknowledges and agrees that upon receipt of an Advance Notice the
Investor will sell the Shares to be issued to the Investor pursuant to the
Advance Notice, even if the Shares have not been delivered to the Investor.

                                   ARTICLE IV.
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

         Except as stated below, on the disclosure schedules attached hereto or
in the SEC Documents (as defined herein), the Company hereby represents and
warrants to, and covenants with, the Investor that the following are true and
correct as of the date hereof:

         Section 4.1 Organization and Qualification. The Company is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority
corporate power to own its properties and to carry on its business as now being
conducted. Each of the Company and its subsidiaries is duly qualified as a
foreign corporation to do business and is in good standing in every jurisdiction
in which the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so qualified or be in
good standing would not have a Material Adverse Effect on the Company and its
subsidiaries taken as a whole.

                                       9
<PAGE>

         Section 4.2 Authorization, Enforcement, Compliance with Other
Instruments. (i) The Company has the requisite corporate power and authority to
enter into and perform this Agreement, the Registration Rights Agreement, the
Escrow Agreement, the Placement Agent Agreement and any related agreements, in
accordance with the terms hereof and thereof, (ii) the execution and delivery of
this Agreement, the Registration Rights Agreement, the Escrow Agreement, the
Placement Agent Agreement and any related agreements by the Company and the
consummation by it of the transactions contemplated hereby and thereby, have
been duly authorized by the Company's Board of Directors and no further consent
or authorization is required by the Company, its Board of Director s or its
stockholders, (iii) this Agreement, the Registration Rights Agreement, the
Escrow Agreement, the Placement Agent Agreement and any related agreements have
been duly executed and delivered by the Company, (iv) this Agreement, the
Registration Rights Agreement, the Escrow Agreement, the Placement Agent
Agreement and assuming the execution and delivery thereof and acceptance by the
Investor and any related agreements constitute the valid and binding obligations
of the Company enforceable against the Company in accordance with their terms,
except as such enforceability may be limited by general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of creditors'
rights and remedies.

         Section 4.3 Capitalization. As of the date hereof, the authorized
capital stock of the Company consists of 100,000,000 shares of Common Stock, par
value $.001 per share and 10,000,000 shares of Preferred Stock, par value $.001
per share of which 12,812,000 shares of Common Stock and no shares of Preferred
Stock were issued and outstanding as of the date hereof. All of such outstanding
shares have been validly issued and are fully paid and nonassessable. Except as
disclosed in the SEC Documents, no shares of Common Stock are subject to
preemptive rights or any other similar rights or any liens or encumbrances
suffered or permitted by the Company. Except as disclosed in the SEC Documents,
as of the date hereof, (i) there are no outstanding options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital
stock of the Company or any of its subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its subsidiaries
is or may become bound to issue additional shares of capital stock of the
Company or any of its subsidiaries or options, warrants, scrip, rights to
subscribe to, calls or commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, (ii) there are no outstanding debt
securities and (iii) there are no agreements or arrangements under which the
Company or any of its subsidiaries is obligated to register the sale of any of
their securities under the Securities Act (except pursuant to the Registration
Rights Agreement). There are no securities or instruments containing
anti-dilution or similar provisions that will be triggered by this Agreement or
any related agreement or the consummation of the transactions described herein
or therein.. The Company has furnished to the Investor true and correct copies
of the Company's Certificate of Incorporation, as amended and as in effect on
the date hereof (the "Certificate of Incorporation"), and the Company's By-laws,
as in effect on the date hereof (the "By-laws"), and the terms of all securities
convertible into or exercisable for Common Stock and the material rights of the
holders thereof in respect thereto.

                                       10
<PAGE>

         Section 4.4 No Conflict. The execution, delivery and performance of
this Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby will not (i) result in a violation of the
Certificate of Incorporation, any certificate of designations of any outstanding
series of preferred stock of the Company or By-laws or (ii) conflict with or
constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its subsidiaries is a party, or result
in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations and the rules and
regulations of the Principal Market on which the Common Stock is quoted)
applicable to the Company or any of its subsidiaries or by which any material
property or asset of the Company or any of its subsidiaries is bound or affected
and which would cause a Material Adverse Effect. Except as disclosed in the SEC
Documents, neither the Company nor its subsidiaries is in violation of any term
of or in default under its Certificate of Incorporation or By-laws or their
organizational charter or by-laws, respectively, or any material contract,
agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or
order or any statute, rule or regulation applicable to the Company or its
subsidiaries. The business of the Company and its subsidiaries is not being
conducted in violation of any material law, ordinance, regulation of any
governmental entity. Except as specifically contemplated by this Agreement and
as required under the Securities Act and any applicable state securities laws,
the Company is not required to obtain any consent, authorization or order of, or
make any filing or registration with, any court or governmental agency in order
for it to execute, deliver or perform any of its obligations under or
contemplated by this Agreement or the Registration Rights Agreement in
accordance with the terms hereof or thereof. All consents, authorizations,
orders, filings and registrations which the Company is required to obtain
pursuant to the preceding sentence have been obtained or effected on or prior to
the date hereof. The Company and its subsidiaries are unaware of any fact or
circumstance, which might give rise to any of the foregoing.

         Section 4.5 SEC Documents; Financial Statements. Since November 3,
2000, the Company has filed all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC under of the Exchange Act. The
Company has delivered to the Investor or its representatives, or made available
through the SEC's website at http://www.sec.gov, true and complete copies of the
SEC Documents. As of their respective dates, the financial statements of the
Company disclosed in the SEC Documents (the "Financial Statements") complied as
to form in all material respects with applicable accounting requirements and the
published rules and regulations of the SEC with respect thereto. Such financial
statements have been prepared in accordance with generally accepted accounting
principles, consistently applied, during the periods involved (except (i) as may
be otherwise indicated in such financial statements or the notes thereto, or
(ii) in the case of unaudited interim statements, to the extent they may exclude
footnotes or may be condensed or summary statements) and, fairly present in all
material respects the financial position of the Company as of the dates thereof
and the results of its operations and cash flows for the periods then ended
(subject, in the case of unaudited statements, to normal year-end audit
adjustments). No other information provided by or on behalf of the Company to
the Investor which is not included in the SEC Documents contains any untrue
statement of a material fact or omits to state any material fact necessary in
order to make the statements therein, in the light of the circumstances under
which they were made, not misleading.

                                       11
<PAGE>

         Section 4.6 10b-5. The SEC Documents do not include any untrue
statements of material fact, nor do they omit to state any material fact
required to be stated therein necessary to make the statements made, in light of
the circumstances under which they were made, not misleading.

         Section 4.7 No Default. Except as disclosed in Section 4.4 or the SEC
Documents, the Company is not in default in the performance or observance of any
material obligation, agreement, covenant or condition contained in any
indenture, mortgage, deed of trust or other material instrument or agreement to
which it is a party or by which it is or its property is bound and neither the
execution, nor the delivery by the Company, nor the performance by the Company
of its obligations under this Agreement or any of the exhibits or attachments
hereto will conflict with or result in the breach or violation of any of the
terms or provisions of, or constitute a default or result in the creation or
imposition of any lien or charge on any assets or properties of the Company
under its Certificate of Incorporation, By-Laws, any material indenture,
mortgage, deed of trust or other material agreement applicable to the Company or
instrument to which the Company is a party or by which it is bound, or any
statute, or any decree, judgment, order, rules or regulation of any court or
governmental agency or body having jurisdiction over the Company or its
properties, in each case which default, lien or charge is likely to cause a
Material Adverse Effect on the Company's business or financial condition.

         Section 4.8 Absence of Events of Default. Except for matters described
in the SEC Documents and/or this Agreement, no Event of Default, as defined in
the respective agreement to which the Company is a party, and no event which,
with the giving of notice or the passage of time or both, would become an Event
of Default (as so defined), has occurred and is continuing, which would have a
Material Adverse Effect on the Company's business, properties, prospects,
financial condition or results of operations.

         Section 4.9 Intellectual Property Rights. The Company and its
subsidiaries own or possess adequate rights or licenses to use all material
trademarks, trade names, service marks, service mark registrations, service
names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and rights necessary to conduct their
respective businesses as now conducted. The Company and its subsidiaries do not
have any knowledge of any infringement by the Company or its subsidiaries of
trademark, trade name rights, patents, patent rights, copyrights, inventions,
licenses, service names, service marks, service mark registrations, trade secret
or other similar rights of others, and, to the knowledge of the Company, there
is no claim, action or proceeding being made or brought against, or to the
Company's knowledge, being threatened against, the Company or its subsidiaries
regarding trademark, trade name, patents, patent rights, invention, copyright,
license, service names, service marks, service mark registrations, trade secret
or other infringement; and the Company and its subsidiaries are unaware of any
facts or circumstances which might give rise to any of the foregoing.

         Section 4.10 Employee Relations. Neither the Company nor any of its
subsidiaries is involved in any labor dispute nor, to the knowledge of the
Company or any of its subsidiaries, is any such dispute threatened. None of the
Company 's or its subsidiaries' employees is a member of a union and the Company
and its subsidiaries believe that their relations with their employees are good.

                                       12
<PAGE>

         Section 4.11 Environmental Laws. The Company and its subsidiaries are
(i) in compliance with any and all applicable material foreign, federal, state
and local laws and regulations relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes, pollutants
or contaminants ("Environmental Laws"), (ii) have received all permits, licenses
or other approvals required of them under applicable Environmental Laws to
conduct their respective businesses and (iii) are in compliance with all terms
and conditions of any such permit, license or approval.

         Section 4.12 Title. Except as set forth in the SEC Documents, the
Company has good and marketable title to its properties and material assets
owned by it, free and clear of any pledge, lien, security interest, encumbrance,
claim or equitable interest other than such as are not material to the business
of the Company. Any real property and facilities held under lease by the Company
and its subsidiaries are held by them under valid, subsisting and enforceable
leases with such exceptions as are not material and do not interfere with the
use made and proposed to be made of such property and buildings by the Company
and its subsidiaries.

         Section 4.13 Insurance. The Company and each of its subsidiaries are
insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as management of the Company believes to be
prudent and customary in the businesses in which the Company and its
subsidiaries are engaged. Neither the Company nor any such subsidiary has been
refused any insurance coverage sought or applied for and neither the Company nor
any such subsidiary has any reason to believe that it will not be able to renew
its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its
business at a cost that would not materially and adversely affect the condition,
financial or otherwise, or the earnings, business or operations of the Company
and its subsidiaries, taken as a whole.

         Section 4.14 Regulatory Permits. The Company and its subsidiaries
possess all material certificates, authorizations and permits issued by the
appropriate federal, state or foreign regulatory authorities necessary to
conduct their respective businesses , and neither the Company nor any such
subsidiary has received any notice of proceedings relating to the revocation or
modification of any such certificate, authorization or permit.

         Section 4.15 Internal Accounting Controls. The Company and each of its
subsidiaries maintain a system of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance
with management's general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with
management's general or specific authorization and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.

         Section 4.16 No Material Adverse Breaches, etc. Except as set forth in
the SEC Documents, neither the Company nor any of its subsidiaries is subject to
any charter, corporate or other legal restriction, or any judgment, decree,
order, rule or regulation which in the judgment of the Company's officers has or

                                       13
<PAGE>

is expected in the future to have a Material Adverse Effect on the business,
properties, operations, financial condition, results of operations or prospects
of the Company or its subsidiaries. Except as set forth in the SEC Documents,
neither the Company nor any of its subsidiaries is in breach of any contract or
agreement which breach, in the judgment of the Company's officers, has or is
expected to have a Material Adverse Effect on the business, properties,
operations, financial condition, results of operations or prospects of the
Company or its subsidiaries.

         Section 4.17 Absence of Litigation. Except as set forth in the SEC
Documents, there is no action, suit, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization
or body pending against or affecting the Company, the Common Stock or any of the
Company's subsidiaries, wherein an unfavorable decision, ruling or finding would
(i) have a Material Adverse Effect on the transactions contemplated hereby (ii)
adversely affect the validity or enforceability of, or the authority or ability
of the Company to perform its obligations under, this Agreement or any of the
documents contemplated herein, or (iii) except as expressly disclosed in the SEC
Documents, have a Material Adverse Effect on the business, operations,
properties, financial condition or results of operation of the Company and its
subsidiaries taken as a whole.

         Section 4.18 Subsidiaries. Except as disclosed in the SEC Documents,
the Company does not presently own or control, directly or indirectly, any
interest in any other corporation, partnership, association or other business
entity.

         Section 4.19 Tax Status. The Company and each of its subsidiaries has
made or filed all federal and state income and all other tax returns, reports
and declarations required by any jurisdiction to which it is subject and (unless
and only to the extent that the Company and each of its subsidiaries has set
aside on its books provisions reasonably adequate for the payment of all unpaid
and unreported taxes) has paid all taxes and other governmental assessments and
charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith
and has set aside on its books provision reasonably adequate for the payment of
all taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the
Company know of no basis for any such claim.

         Section 4.20 Certain Transactions. Except as set forth in the SEC
Documents none of the officers, directors, or employees of the Company is
presently a party to any transaction with the Company (other than for services
as employees, officers and directors), including any contract, agreement or
other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, or otherwise requiring
payments to or from any officer, director or such employee or, to the knowledge
of the Company, any corporation, partnership, trust or other entity in which any
officer, director, or any such employee has a substantial interest or is an
officer, director, trustee or partner.

         Section 4.21 Fees and Rights of First Refusal. Except as set forth in
the SEC Documents, the Company is not obligated to offer the securities offered
hereunder on a right of first refusal basis or otherwise to any third parties
including, but not limited to, current or former shareholders of the Company,
underwriters, brokers, agents or other third parties.

                                       14
<PAGE>

         Section 4.22 Use of Proceeds. The Company represents that the net
proceeds from this offering will be used for general corporate purposes.
However, in no event shall the net proceeds from this offering be used by the
Company for the payment (or loaned to any such person for the payment) of any
judgment, or other liability, incurred by any executive officer, officer,
director or employee of the Company, except for any liability owed to such
person for services rendered, or if any judgment or other liability is incurred
by such person originating from services rendered to the Company, or the Company
has indemnified such person from liability.

         Section 4.23 Further Representation and Warranties of the Company. For
so long as any securities issuable hereunder held by the Investor remain
outstanding, the Company acknowledges, represents, warrants and agrees that it
will maintain the listing of its Common Stock on the Principal Market

         Section 4.24 Opinion of Counsel. Investor shall receive an opinion
letter from Newman, Pollock & Klein, LLP, counsel to the Company (updated where
applicable) on the date hereof.

         Section 4.25 Opinion of Counsel. The Company will obtain for the
Investor, at the Company's expense, any and all opinions of counsel which may be
reasonably required in order to sell the securities issuable hereunder without
restriction.

         Section 4.26 Dilution. The Company is aware and acknowledges that
issuance of shares of the Company's Common Stock could cause dilution to
existing shareholders and could significantly increase the outstanding number of
shares of Common Stock.

                                   ARTICLE V.
                                 INDEMNIFICATION

         The Investor and the Company represent to the other the following with
respect to itself:

         Section 5.1       Indemnification.

                  (a) In consideration of the Investor's execution and delivery
of this Agreement, and in addition to all of the Company's other obligations
under this Agreement, the Company shall defend, protect, indemnify and hold
harmless the Investor, and all of its officers, directors, partners, employees
and agents (including, without limitation, those retained in connection with the
transactions contemplated by this Agreement) (collectively, the "Investor
Indemnitees") from and against any and all actions, causes of action, suits,
claims, losses, costs, penalties, fees, liabilities and damages, and expenses in
connection therewith (irrespective of whether any such Investor Indemnitee is a
party to the action for which indemnification hereunder is sought), and
including reasonable attorneys' fees and disbursements (the "Indemnified
Liabilities"), incurred by the Investor Indemnitees or any of them as a result
of, or arising out of, or relating to (a) any misrepresentation or breach of any
representation or warranty made by the Company in this Agreement or the
Registration Rights Agreement or any other certificate, instrument or document
contemplated hereby or thereby, (b) any breach of any covenant, agreement or
obligation of the Company contained in this Agreement or the Registration Rights
Agreement or any other certificate, instrument or document contemplated hereby
or thereby, or (c) any cause of action, suit or claim brought or made against
such Investor Indemnitee not arising out of any action or inaction of an
Investor Indemnitee, and arising out of or resulting from the execution,

                                       15
<PAGE>

delivery, performance or enforcement of this Agreement or any other instrument,
document or agreement executed pursuant hereto by any of the Investor
Indemnitees. To the extent that the foregoing undertaking by the Company may be
unenforceable for any reason, the Company shall make the maximum contribution to
the payment and satisfaction of each of the Indemnified Liabilities, which is
permissible under applicable law.

                  (b) In consideration of the Company's execution and delivery
of this Agreement, and in addition to all of the Investor's other obligations
under this Agreement, the Investor shall defend, protect, indemnify and hold
harmless the Company and all of its officers, directors, shareholders, employees
and agents (including, without limitation, those retained in connection with the
transactions contemplated by this Agreement) (collectively, the "Company
Indemnitees") from and against any and all Indemnified Liabilities incurred by
the Company Indemnitees or any of them as a result of, or arising out of, or
relating to (a) any misrepresentation or breach of any representation or
warranty made by the Investor in this Agreement, the Registration Rights
Agreement, or any instrument or document contemplated hereby or thereby executed
by the Investor, (b) any breach of any covenant, agreement or obligation of the
Investor(s) contained in this Agreement, the Registration Rights Agreement or
any other certificate, instrument or document contemplated hereby or thereby
executed by the Investor, or (c) any cause of action, suit or claim brought or
made against such Company Indemnitee based on misrepresentations or due to a
breach by the Investor and arising out of or resulting from the execution,
delivery, performance or enforcement of this Agreement or any other instrument,
document or agreement executed pursuant hereto by any of the Company
Indemnitees. To the extent that the foregoing undertaking by the Investor may be
unenforceable for any reason, the Investor shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities, which is
permissible under applicable law.

                                   ARTICLE VI.
                            COVENANTS OF THE COMPANY

         Section 6.1 Registration Rights. The Company shall cause the
Registration Rights Agreement to remain in full force and effect and the Company
shall comply in all material respects with the terms thereof.

         Section 6.2 Listing of Common Stock. The Company shall maintain the
Common Stock' s authorization for quotation on the National Association of
Securities Dealers Over the Counter Bulletin Board.

         Section 6.3 Exchange Act Registration. The Company will cause its
Common Stock to continue to be registered under Section 12(g) of the Exchange
Act, will file in a timely manner all reports and other documents required of it
as a reporting company under the Exchange Act and will not take any action or
file any document (whether or not permitted by Exchange Act or the rules there
under to terminate or suspend such registration or to terminate or suspend its
reporting and filing obligations under said Exchange Act.

                                       16
<PAGE>

         Section 6.4 Transfer Agent Instructions. Not later than two (2)
business days after each Advance Notice Date and prior to each Closing and the
effectiveness of the Registration Statement and resale of the Common Stock by
the Investor, the Company will deliver instructions to its transfer agent to
issue shares of Common Stock free of restrictive legends.

         Section 6.5 Corporate Existence. The Company will take all steps
necessary to preserve and continue the corporate existence of the Company.

         Section 6.6 Notice of Certain Events Affecting Registration; Suspension
of Right to Make an Advance. The Company will immediately notify the Investor
upon its becoming aware of the occurrence of any of the following events in
respect of a registration statement or related prospectus relating to an
offering of Registrable Securities: (i) receipt of any request for additional
information by the SEC or any other Federal or state governmental authority
during the period of effectiveness of the Registration Statement for amendments
or supplements to the registration statement or related prospectus; (ii) the
issuance by the SEC or any other Federal or state governmental authority of any
stop order suspending the effectiveness of the Registration Statement or the
initiation of any proceedings for that purpose; (iii) receipt of any
notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any
jurisdiction or the initiation or threatening of any proceeding for such
purpose; (iv) the happening of any event that makes any statement made in the
Registration Statement or related prospectus of any document incorporated or
deemed to be incorporated therein by reference untrue in any material respect or
that requires the making of any changes in the Registration Statement, related
prospectus or documents so that, in the case of the Registration Statement, it
will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein not misleading, and that in the case of the related prospectus, it will
not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not
misleading; and (v) the Company's reasonable determination that a post-effective
amendment to the Registration Statement would be appropriate; and the Company
will promptly make available to the Investor any such supplement or amendment to
the related prospectus. The Company shall not deliver to the Investor any
Advance Notice during the continuation of any of the foregoing events.

         Section 6.7 Expectations Regarding Advance Notices. Within ten (10)
days after the commencement of each calendar quarter occurring subsequent to the
commencement of the Commitment Period, the Company must notify the Investor, in
writing, as to its reasonable expectations as to the dollar amount it intends to
raise during such calendar quarter, if any, through the issuance of Advance
Notices. Such notification shall constitute only the Company's good faith
estimate and shall in no way obligate the Company to raise such amount, or any
amount, or otherwise limit its ability to deliver Advance Notices. The failure
by the Company to comply with this provision can be cured by the Company's
notifying the Investor, in writing, at any time as to its reasonable
expectations with respect to the current calendar quarter.

         Section 6.8 Consent of Investor to Sell Common Stock. During the
Commitment Period, the Company shall not issue or sell (i) any Common Stock
without consideration or for a consideration per share less than its Bid Price
determined immediately prior to its issuance, (ii) issue or sell any warrant,

                                       17
<PAGE>

option, right, contract, call, or other security or instrument granting the
holder thereof the right to acquire Common Stock without consideration or for a
consideration per share less than such Common Stock's Bid Price determined
immediately prior to its issuance, or (iii) file any registration statement on
Form S-8.

         Section 6.9 Consolidation; Merger. The Company shall not, at any time
after the date hereof, effect any merger or consolidation of the Company with or
into, or a transfer of all or substantially all the assets of the Company to
another entity (a "Consolidation Event") unless the resulting successor or
acquiring entity (if not the Company) assumes by written instrument the
obligation to deliver to the Investor such shares of stock and/or securities as
the Investor is entitled to receive pursuant to this Agreement.

         Section 6.10 Issuance of the Company's Common Stock. The sale of the
shares of Common Stock shall be made in accordance with the provisions and
requirements of Regulation D and any applicable state securities law.

                                  ARTICLE VII.
                CONDITIONS FOR ADVANCE AND CONDITIONS TO CLOSING

         Section 7.1 Conditions Precedent to the Obligations of the Company. The
obligation hereunder of the Company to issue and sell the shares of Common Stock
to the Investor incident to each Closing is subject to the satisfaction, or
waiver by the Company, at or before each such Closing, of each of the conditions
set forth below.

                  (a) Accuracy of the Investor's Representations and Warranties.
The representations and warranties of the Investor shall be true and correct in
all material respects.

                  (b) Performance by the Investor. The Investor shall have
performed, satisfied and complied in all respects with all covenants, agreements
and conditions required by this Agreement and the Registration Rights Agreement
to be performed, satisfied or complied with by the Investor at or prior to such
Closing.

         Section 7.2 Conditions Precedent to the Right of the Company to Deliver
an Advance Notice and the Obligation of the Investor to Purchase Shares of
Common Stock. The right of the Company to deliver an Advance Notice and the
obligation of the Investor hereunder to acquire and pay for shares of the
Company's Common Stock incident to a Closing is subject to the satisfaction or
waiver by the Investor, on (i) the date of delivery of such Advance Notice and
(ii) the applicable Advance Date (each a "Condition Satisfaction Date"), of each
of the following conditions:

                  (a) Registration of the Common Stock with the SEC. The Company
shall have filed with the SEC a Registration Statement with respect to the
resale of the Registrable Securities in accordance with the terms of the
Registration Rights Agreement. As set forth in the Registration Rights
Agreement, the Registration Statement shall have previously become effective and
shall remain effective on each Condition Satisfaction Date and (i) neither the
Company nor the Investor shall have received notice that the SEC has issued or
intends to issue a stop order with respect to the Registration Statement or that
the SEC otherwise has suspended or withdrawn the effectiveness of the
Registration Statement, either temporarily or permanently, or intends or has

                                       18
<PAGE>

threatened to do so (unless the SEC's concerns have been addressed and the
Investor is reasonably satisfied that the SEC no longer is considering or
intends to take such action), and (ii) no other suspension of the use or
withdrawal of the effectiveness of the Registration Statement or related
prospectus shall exist. The Registration Statement must have been declared
effective by the SEC prior to the first Advance Notice Date.

                  (b) Authority. The Company shall have obtained all permits and
qualifications required by any applicable state in accordance with the
Registration Rights Agreement for the offer and sale of the shares of Common
Stock, or shall have the availability of exemptions there from. The sale and
issuance of the shares of Common Stock shall be legally permitted by all laws
and regulations to which the Company is subject.

                  (c) Fundamental Changes. There shall not exist any fundamental
changes to the information set forth in the Registration Statement which would
require the Company to file a post-effective amendment to the Registration
Statement.

                  (d) Performance by the Company. The Company shall have
performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by this Agreement (including, without
limitation, the conditions specified in Section 2.5 hereof) and the Registration
Rights Agreement to be performed, satisfied or complied with by the Company at
or prior to each Condition Satisfaction Date.

                  (e) No Injunction. No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction that prohibits or directly and adversely affects any of the
transactions contemplated by this Agreement, and no proceeding shall have been
commenced that may have the effect of prohibiting or adversely affecting any of
the transactions contemplated by this Agreement.

                  (f) No Suspension of Trading in or Delisting of Common Stock.
The trading of the Common Stock is not suspended by the SEC or the Principal
Market (if the Common Stock is traded on a Principal Market). The issuance of
shares of Common Stock with respect to the applicable Closing, if any, shall not
violate the shareholder approval requirements of the Principal Market (if the
Common Stock is traded on a Principal market). The Company shall not have
received any notice threatening the continued listing of the Common Stock on the
Principal Market (if the Common Stock is traded on a Principal Market).

                  (g) Maximum Advance Amount. The amount of the individual
Advance requested by the Company does not exceed the Maximum Advance Amount
unless waived by the Investor. In addition, in no event shall the number of
shares issuable to the Investor pursuant to an Advance cause the Investor to own
in excess of nine and 9/10 percent (9.9%) of the then outstanding Common Stock
of the Company.

                  (h) No Knowledge. The Company has no knowledge of any event
more likely than not to have the effect of causing such Registration Statement
to be suspended or otherwise ineffective.

                                       19
<PAGE>

                  (i) Other. On each Condition Satisfaction Date, the Investor
shall have received and been reasonably satisfied with such other certificates
and documents as shall have been reasonably requested by the Investor in order
for the Investor to confirm the Company's satisfaction of the conditions set
forth in this Section 7.2, including, without limitation, a certificate executed
by an executive officer of the Company and to the effect that all the conditions
to such Closing shall have been satisfied as at the date of each such
certificate substantially in the form annexed hereto on Exhibit A.

                                  ARTICLE VIII.
         DUE DILIGENCE REVIEW; NON-DISCLOSURE OF NON-PUBLIC INFORMATION

         Section 8.1 Due Diligence Review. Prior to the filing of the
Registration Statement the Company shall make available for inspection and
review by the Investor, advisors to and representatives of the Investor, any
underwriter participating in any disposition of the Registrable Securities on
behalf of the Investor pursuant to the Registration Statement, any such
registration statement or amendment or supplement thereto or any blue sky, NASD
or other filing, all financial and other records, all SEC Documents and other
filings with the SEC, and all other corporate documents and properties of the
Company as may be reasonably necessary for the purpose of such review, and cause
the Company's officers, directors and employees to supply all such information
reasonably requested by the Investor or any such representative, advisor or
underwriter in connection with such Registration Statement (including, without
limitation, in response to all questions and other inquiries reasonably made or
submitted by any of them), prior to and from time to time after the filing and
effectiveness of the Registration Statement for the sole purpose of enabling the
Investor and such representatives, advisors and underwriters and their
respective accountants and attorneys to conduct initial and ongoing due
diligence with respect to the Company and the accuracy of the Registration
Statement.

         Section 8.2       Non-Disclosure of Non-Public Information.

                  (a) The Company shall not disclose non-public information to
the Investor, advisors to or representatives of the Investor unless prior to
disclosure of such information the Company identifies such information as being
non-public information and provides the Investor, such advisors and
representatives with the opportunity to accept or refuse to accept such
non-public information for review. The Company may, as a condition to disclosing
any non-public information hereunder, require the Investor's advisors and
representatives to enter into a confidentiality agreement in form reasonably
satisfactory to the Company and the Investor.

                  (b) Nothing herein shall require the Company to disclose
non-public information to the Investor or its advisors or representatives, and
the Company represents that it does not disseminate non-public information to
any investors who purchase stock in the Company in a public offering, to money
managers or to securities analysts, provided, however, that notwithstanding
anything herein to the contrary, the Company will, as hereinabove provided,
immediately notify the advisors and representatives of the Investor and, if any,
underwriters, of any event or the existence of any circumstance (without any
obligation to disclose the specific event or circumstance) of which it becomes
aware, constituting non-public information (whether or not requested of the
Company specifically or generally during the course of due diligence by such
persons or entities), which, if not disclosed in the prospectus included in the

                                       20
<PAGE>

Registration Statement would cause such prospectus to include a material
misstatement or to omit a material fact required to be stated therein in order
to make the statements, therein, in light of the circumstances in which they
were made, not misleading. Nothing contained in this Section 8.2 shall be
construed to mean that such persons or entities other than the Investor (without
the written consent of the Investor prior to disclosure of such information) may
not obtain non-public information in the course of conducting due diligence in
accordance with the terms of this Agreement and nothing herein shall prevent any
such persons or entities from notifying the Company of their opinion that based
on such due diligence by such persons or entities, that the Registration
Statement contains an untrue statement of material fact or omits a material fact
required to be stated in the Registration Statement or necessary to make the
statements contained therein, in light of the circumstances in which they were
made, not misleading.

                                   ARTICLE IX.
                           CHOICE OF LAW/JURISDICTION

         Section 9.1 Governing Law. This Agreement shall be governed by and
interpreted in accordance with the laws of the State of New Jersey without
regard to the principles of conflict of laws. The parties further agree that any
action between them shall be heard in Hudson County, New Jersey, and expressly
consent to the jurisdiction and venue of the Superior Court of New Jersey,
sitting in Hudson County, New Jersey and the United States District Court of New
Jersey, sitting in Newark, New Jersey, for the adjudication of any civil action
asserted pursuant to this paragraph.

                                   ARTICLE X.
                             ASSIGNMENT; TERMINATION

         Section 10.1 Assignment. Neither this Agreement nor any rights of the
Company hereunder may be assigned to any other Person.

         Section 10.2 Termination. The obligations of the Investor to make
Advance s under Article II hereof shall terminate twenty-four (24) months after
the Effective Date.

                                   ARTICLE XI
                                     NOTICES

         Section 11.1 Notices. Any notices, consents, waivers, or other
communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered (i) upon
receipt, when delivered personally; (ii) upon receipt, when sent by facsimile,
provided a copy is mailed by U.S. certified mail, return receipt requested;
(iii) three (3) days after being sent by U.S. certified mail, return receipt
requested, or (iv) one (1) day after deposit with a nationally recognized
overnight delivery service, in each case properly addressed to the party to
receive the same. The addresses and facsimile numbers for such communications
shall be:

                                       21
<PAGE>

If to the Company, to:              Bio-One Corporation
                                    1630 Winter Springs Blvd.
                                    Winter Springs, Florida 32708
                                    Attention:  Armand Dauplaise
                                                President
                                    Telephone:  (407) 977-1005
                                    Facsimile:  (407) 977-1186

With a copy to:                     Newman, Pollock & Klein, LLP
                                    2101 N.W. Corporate Boulevard -  Suite 414
                                    Boca Raton, Florida 33431
                                    Attention:  Irwin Newman, Esq.
                                    Telephone:  (561) 997-9920
                                    Facsimile:  (561) 241-4943

If to the Investor(s):              Cornell Capital Partners, LP
                                    101 Hudson Street -Suite 3606
                                    Jersey City, NJ 07302
                                    Attention:  Mark Angelo
                                                Portfolio Manager
                                    Telephone:  (201) 985-8300
                                    Facsimile:  (201) 985-8266

With a Copy to:                     Butler Gonzalez LLP
                                    1000 Stuyvesant Avenue - Suite 6
                                    Union, NJ 07083
                                    Attention:  David Gonzalez, Esq.
                                    Telephone:  (908) 810-8588
                                    Facsimile:  (908) 810-0973

Each party shall provide five (5) days prior written notice to the other party
of any change in address or facsimile number.

                                  ARTICLE XII.
                                  MISCELLANEOUS

         Section 12.1 Counterparts. This Agreement may be executed in two or
more identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each
party and delivered to the other party. In the event any signature page is
delivered by facsimile transmission, the party using such means of delivery
shall cause four (4) additional original executed signature pages to be
physically delivered to the other party within five (5) days of the execution
and delivery hereof.

                                       22
<PAGE>

         Section 12.2 Entire Agreement; Amendments. This Agreement supersedes
all other prior oral or written agreements between the Investor, the Company,
their affiliates and persons acting on their behalf with respect to the matters
discussed herein, and this Agreement and the instruments referenced herein
contain the entire understanding of the parties with respect to the matters
covered herein and therein and, except as specifically set forth herein or
therein, neither the Company nor the Investor makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of
this Agreement may be waived or amended other than by an instrument in writing
signed by the party to be charged with enforcement.

         Section 12.3 Reporting Entity for the Common Stock. The reporting
entity relied upon for the determination of the trading price or trading volume
of the Common Stock on any given Trading Day for the purposes of this Agreement
shall be Bloomberg, L.P. or any successor thereto. The written mutual consent of
the Investor and the Company shall be required to employ any other reporting
entity.

         Section 12.4 Fees and Expenses. The Company hereby agrees to pay the
following fees:

                  (a) Legal Fees. Each of the parties shall pay its own fees and
expenses (including the fees of any attorneys, accountants, appraisers or others
engaged by such party) in connection with this Agreement and the transactions
contemplated hereby, except that the Company will pay the sum of Fifteen
Thousand Dollars ($15,000), to Butler Gonzalez LLP for legal, administrative,
and escrow fees either upon the execution of this Agreement. Subsequently on
each advance date, the Company will pay Butler Gonzalez LLP, the sum of Five
Hundred Dollars ($500) for legal, administrative and escrow fees of Kirkpatrick
& Lockhart LLP directly out the proceeds of any Advances hereunder.

                  (b) Commitment Fees.

                           (i) On each Advance Date the Company shall pay to the
Investor, directly from the gross proceeds held in escrow, an amount equal to
five percent (5%) of the amount of each Advance. The Company hereby agrees that
if such payment, as is described above, is not made by the Company on the
Advance Date, such payment will be made at the direction of the Investor as
outlined and mandated by Section 2.3 of this Agreement.

                           (ii) Upon the execution of this Agreement the Company
shall issue to the Investor shares of the Company' s Common Stock in an amount
equal to Three Hundred Forty Thousand Dollars ($340,000) divided by the Closing
Bid Price on the Closing Date (the "Investor's Shares").

                           (iii) Fully Earned. Any Investor's Shares issued to
the Investor shall be deemed fully earned as of the date hereof.

                           (iv) Registration Rights. The Investor's Shares will
have demand and "piggy-back" registration rights.

         Section 12.5 Brokerage. Each of the parties hereto represents that it
has had no dealings in connection with this transaction with any finder or
broker who will demand payment of any fee or commission from the other party.
The Company on the one hand, and the Investor, on the other hand, agree to
indemnify the other against and hold the other harmless from any and all
liabilities to any person claiming brokerage commissions or finder's fees on
account of services purported to have been rendered on behalf of the
indemnifying party in connection with this Agreement or the transactions
contemplated hereby.

                                       23
<PAGE>

         Section 12.6 Confidentiality. If for any reason the transactions
contemplated by this Agreement are not consummated, each of the parties hereto
shall keep confidential any information obtained from any other party (except
information publicly available or in such party's domain prior to the date
hereof, and except as required by court order) and shall promptly return to the
other parties all schedules, documents, instruments, work papers or other
written information without retaining copies there of, previously furnished by
it as a result of this Agreement or in connection herein.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       24
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Equity Line of
Credit Agreement to be executed by the undersigned, thereunto duly authorized,
as of the date first set forth above.

                                               COMPANY:
                                               BIO-ONE CORPORATION

                                               By: /s/ Armand Dauplaise
                                               Name: Armand Dauplaise
                                               Title:   President

                                               INVESTOR:
                                               CORNELL CAPITAL PARTNERS, LP

                                               By: Yorkville Advisors, LLC
                                               Its: General Partner

                                               By: /s/ Mark Angelo
                                               Name:    Mark Angelo
                                               Title: Portfolio Manager

                                       25
<PAGE>

                                    EXHIBIT A
                                    ---------

                      ADVANCE NOTICE/COMPLIANCE CERTIFICATE
                      -------------------------------------

BIO-ONE CORPORATION

The undersigned, ________________________________ hereby certifies, with respect
to the sale of shares of Common Stock of Bio-One Corporation. (the "Company "),
issuable in connection with this Advance Notice and Compliance Certificate dated
___________________ (the "Notice"), delivered pursuant to the Equity Line of
Credit Agreement (the "Agreement"), as follows:

         1. The undersigned is the duly elected President and Chief Executive
Officer of the Company.

         2. There are no fundamental changes to the information set forth in the
Registration Statement which would require the Company to file a post effective
amendment to the Registration Statement.

         3. The Company has performed in all material respects all covenants and
agreements to be performed by the Company on or prior to the Advance Date
related to the Notice and has complied in all material respects with all
obligations and conditions contained in the Agreement.

         4. The Advance requested is _____________________.

         The undersigned has executed this Certificate this ____ day of
_________________.

BIO-ONE CORPORATION

By:      ______________________________

Name:    Armand Dauplaise

Title:   President & CEO

<PAGE>

                                SCHEDULED 2.6(B)
                                ----------------

BIO-ONE CORPORATION
-------------------

         The undersigned hereby agrees that for a period commencing on the date
hereof and expiring on the termination of the Agreement dated ________________
between Bio-One Corporation. (the "Company"), and Cornell Capital Partners, LP,
(the "Investor") (the "Lock-up Period"), he, she or it will not, directly or
indirectly, without the prior written consent of the Investor, issue, offer,
agree or offer to sell, sell, grant an option for the purchase or sale of,
transfer, pledge, assign, hypothecate, distribute or otherwise encumber or
dispose of except pursuant to Rule 144 of the General Rules and Regulations
under the Securities Act of 1933, any securities of the Company, including
common stock or options, rights, warrants or other securities underlying,
convertible into, exchangeable or exercisable for or evidencing any right to
purchase or subscribe for any common stock (whether or not beneficially owned by
the undersigned), or any beneficial interest therein (collectively, the
"Securities").

         In order to enable the aforesaid covenants to be enforced, the
undersigned hereby consents to the placing of legends and/or stop-transfer
orders with the transfer agent of the Company's securities with respect to any
of the Securities registered in the name of the undersigned or beneficially
owned by the undersigned, and the undersigned hereby confirms the undersigned's
investment in the Company.

Dated: _______________, 2002

Signature

Name:
Address:
City, State, Zip Code:
Print Social Security Number
or Taxpayer I.D. NumberExhibit 10.8

INVESTORS CORPORATION
--------------------------------------------------------------------------------

VIA Email

January 10th, 2003

MR. ARMAND DAUPLAISE
President & CEO
Bio-One Corporation
1630 Winter Springs Boulevard
Winter Springs,  Florida 32708

Dear Sir,

You have provided us with certain information and have discussed with us the
financing of Bio-One Corporation's strategic acquisitions and to provide ongoing
working capital.

In connection therewith, based upon the preliminary information available to us,
we are pleased to submit our proposal to provide a senior secured Revolving
Credit Facility and a Term Loan Facility of up to US$15,000,000 (Fifteen Million
US Dollars) to the Company. The exact structure and terms of the proposed Credit
Facility cannot be precisely stated until the completion of our field
examinations and credit investigations. However, in general, we contemplate that
the Credit Facility may be structured as follows:

BORROWER:      Bio-One Corporation together with each of its subsidiaries and
               affiliates (the "Borrower").

LENDER:        Investors Corporation together with it's affiliates and
               associated financial institutions (the "Lender")

FACILITY:      A Senior secured Credit Facility up to an amount equal to the
               lesser of (a) US$15,000,000 (Fifteen Million US Dollars) or (b)
               the Borrowing Base as defined.

PURPOSE:       To acquire specific strategic acquisitions and provide ongoing
               working capital to the Borrower.

--------------------------------------------------------------------------------

OFFICES:
Canada, United Kingdom, Hong Kong, Cayman Islands, Channel Islands,
Guernsey & Ireland

<PAGE>

1.       REVOLVING LOAN FACILITY

         (a)      Amount: Revolving Loan Facility of up to US$5,000,000 (Five
                  Million US Dollars) based upon the lending formulas, subject
                  to the limits and other terms described below.

         (b)      Lending Formulas:

                  (i)      Accounts Receivable: Up to 85% of the net amount of
                           eligible accounts receivable of the Company. Eligible
                           accounts receivable and the net amounts thereof will
                           be determined by us pursuant to general criteria
                           which will be set forth in the loan documentation.
                           Generally eligible accounts receivable will exclude
                           accounts which are unpaid more than 30 days past the
                           original due date thereof, accounts owed by an
                           account debtor which has more than 50% of the
                           aggregated amount thereof unpaid more than such
                           number of days past the original invoice date thereof
                           and/or due date, contra accounts, poor credits,
                           employee or affiliate accounts receivable, and those
                           other accounts which do not constitute collateral
                           acceptable for lending purposes pursuant to criteria
                           established by us.

                  (ii)     Inventory: Up to 50% of the value of finished goods
                           inventory and Work-In-Progress Inventory of the
                           Company valued at the lower of cost or market, as
                           determined by us, with cost determined under the
                           first-in-first-out method. Such advance rate is
                           subject to results satisfactory to us of an appraisal
                           of the inventory to be conducted at your expense by
                           independent appraisers acceptable to us, and will not
                           exceed 75% of net orderly liquidation value per
                           appraisal. Eligible inventory will be determined by
                           us pursuant to general criteria, which will be set
                           forth in the loan documentation. Generally, eligible
                           inventory will exclude packaging, slow moving or
                           obsolete inventory, and those other items which do
                           not constitute collateral acceptable for lending
                           purposes pursuant to criteria established by us.

2.       TERM LOAN FACILITY

         (a)      Amount: A Term Loan Facility of up to the lessor of
                  US$10,000,000 (Ten Million US Dollars) or 90% of net
                  liquidation net of expenses per appraisal of the strategic
                  business acquisitions. Such value will be as determined by
                  appraisals, conducted at your expense, by independent business
                  appraisers acceptable to us. Eligible acquisition companies
                  will be determined by us.

         (b)      Amortization: The Term Loan of US$10,000,000 (Ten Million US
                  Dollars) will be repaid in consecutive equal monthly
                  installments of principal commencing on the 1st (first) day of
                  the month after the closing and on the 1st (first) day of each
                  month thereafter. The amount of each monthly installment will
                  be calculated based on a 48 (forty eight) month amortization,
                  with the final installments to be in the then remaining
                  balance of the Term Loan (and including principal, interest
                  and other amounts) due on the earlier of: (1) the 1st (first)
                  day of the 48th (forty eighth) month after the closing or (2)
                  the termination or non-renewal of the Credit Facility or a
                  default under our financing agreements. Additionally the
                  amortization schedule shall allow for interest only payments
                  for a period of 6 (six) months.

                                       2
<PAGE>

                  Installments of principal on the US$10,000,000 (Ten Million US
                  Dollars) shall commence on the 1st (first) day of the month
                  after the 6th (sixth) month period and on the 1st (first) day
                  of each month thereafter for a period of 42 (forty two)
                  months. With a balloon payment of the principal balance
                  payable on the 1st (first) day of the 49th (forty ninth) month
                  of the funding date.

3.       COLLATERAL

         All obligations of the Company and any corporate guarantors to us will
         be secured by first and only security interests in and liens upon all
         present and future assets of the Company and any corporate guarantors,
         including all accounts, contract rights, general intangibles, chattel
         paper, documents, instruments, deposit accounts, investment property,
         inventory, equipment, fixtures and real property, and all products and
         proceeds thereof. With respect to any real estate collateral, receipt
         of title of insurance policies in amount, form and from an issuer
         satisfactory to the Lender or a title opinion from Borrowers counsel in
         form and substance satisfactory to the lender.

4.       INTEREST RATE

         The interest rate on the Revolving Loan Facility will be 3.00% per
         annum above the US PRIME RATE reported and announced from time to time
         in the Wall Street Journal. Interest on the Term Loan Facility will be
         3.25% above the US PRIME RATE. Interest on the Facility shall be
         computed on the basis of a 360 (three hundred and sixty) day year on
         the 1st (first) day of each month for the preceding month, and shall be
         charged on the average daily outstanding balances of the Facility
         during the preceding month and shall be paid monthly in arrears. In the
         event of a default, the above rates is subject to a premium of 3.00%
         per annum after default, for so long as it continues.

5.       FEES

         All fees listed below are in addition to interest and other fees and
         charges provided for herein and may, at our option, be charged directly
         to any loan accounts of the Company maintained with us.

         (a)      Closing Fee: 1.50% of the Credit Facility, earned and payable
                  in full at closing. If, at the request of the Company, we
                  elect to issue a commitment letter, the closing fee will be
                  payable to us upon issuance of the commitment letter as a
                  non-refundable commitment fee.

         (b)      Servicing Fee: US$1,000 (One Thousand US Dollars) for each
                  month or part thereof during the term of the arrangements,
                  payable monthly in advance.

         (c)      Early Termination Fee: If the Credit Facility is terminated
                  for any reason prior to the end of the then current term:

                  2% of the Credit Facility if terminated on or prior to the
                  first anniversary of the date of closing;

                  1% of the Credit Facility if terminated after the first
                  anniversary and on or prior to the second anniversary of the
                  date of closing; and

                  0.5% of the Credit Facility if terminated after the second
                  anniversary and prior to the third anniversary of the date of
                  closing or at any other time prior to the end of the then
                  current term.

                                       3
<PAGE>

6.       TERM

         The Credit Facility will have an initial term of 4 (four) years from
         the date of closing, with a 5th (fifth) year at our option and
         automatic annual renewals thereafter unless either party gives 60
         (sixty) days prior written notice to the other party of the intention
         to terminate the Credit Facility.

7.       EXPENSES

         You agree to pay all reasonable legal and closing expenses, including
         attorneys' fees and disbursements, filing and search fees, underwriting
         and due diligence expenses, appraisal fees and field examination
         expenses and per diem field examination charges, whether or not this
         transaction closes. We charge US$1,000 (One Thousand US Dollars) per
         person per day for our field examiners in the field and in the office,
         plus travel, hotel and all other out-of-pocket expenses. All such
         expenses shall be paid to us upon demand, together with such advance
         funds on account of such expenses and charges as we may from time to
         time request. This Section shall survive the expiration or termination
         of this letter.

8.       OTHER TERMS AND CONDITIONS

         This proposal does not represent a commitment to lend. Our proposal is
         expressly subject to review of certain other information, satisfactory
         completion of our field examinations, credit investigations and
         analysis and approval by our credit committee. Such approval, if
         obtained at all, shall be contingent upon a closing taking place within
         45 (forty five) days thereafter, after which time this proposal will
         require reapproval by our credit committee even if we continue to work
         on this transaction. Such reapproval, if obtained, may result in
         different terms or conditions, or in a determination not to consummate
         the transaction. No commitment to lend shall be implied from any action
         by us or on our behalf. Communication to you of credit committee
         approval or reapproval shall not constitute a commitment to lend,
         unless expressly so stated in a commitment letter signed by you and us.

         In addition, subject to such conditions as may be established in
         connection with the credit approval, we would anticipate that the
         closing of the Credit Facility would be subject to the satisfaction, in
         a manner acceptable to us, of the following:

         The Company continuing to furnish us with all financial information,
         projections, budgets, business plans, cash flows and such other
         information as we reasonably request from time to time.

         We shall have received current perpetual inventory records and/or
         rollforwards of accounts and inventory through the date of closing,
         together with supporting documentation, and other documents and
         information that will enable us to accurately identify and verify the
         eligible collateral at/or before closing in a manner satisfactory to
         us. We may require daily or weekly reporting of collateral information
         from the Company and/or may establish in our records a loan account for
         the Company prior to closing. Such actions should not be construed as a
         commitment to lend or to waive or modify any conditions to lending.

                                       4
<PAGE>

         The Company shall have provided to us balance sheet, income statements,
         cashflow, and availability projections (including the assumptions
         underlying such projections), all in a level of detail acceptable to
         us, prepared on a monthly basis for the first year of the contract term
         and on a quarterly basis thereafter on all strategic acquisitions.

         Satisfactory legal review of the terms of the Credit Facility and its
         structure by our counsel, and execution and delivery of loan documents,
         all in form and substance satisfactory to us. The loan documents will
         include, among other documents, a loan agreement, security agreements,
         UCC financing statements, intercreditor agreements (if applicable),
         agreements from certain third parties, opinion letters of counsel.

         Such loan documents will contain provisions, representations,
         warranties, conditions, covenants and events of default satisfactory to
         our counsel and us. Financial covenants will require the Companies to
         maintain tangible net worth in an amount to be determined, which amount
         will be acceptable to us and to you, and to maintain a minimum fixed
         charge coverage ratio and EBITDA.

         The excess availability under the lending formulas provided for above,
         subject to sublimits and reserves, shall be not less than US$1,000,000
         (One Million US Dollars) at the closing, and US$150,000 (One Hundred
         and Fifty Thousand US Dollars) at all times thereafter, after the
         payment of fees and expenses of the transactions and the application of
         the proceeds of the initial loans, and after deductions for past due
         payables and other obligations. Accounts payable of the Companies must
         be at a level and in a condition reasonably acceptable to us.

         The Term Loan to be held in Trust subject to the Purchase, Terms &
         Conditions of the company's strategic acquisitions.

         Satisfactory receipt and review of lease agreements of any of the
         acquired Companies leased locations to cover a period of at least 24
         (twenty four) months.

         No material adverse change in the business, operations, profits or
         prospects of the acquisition Companies or in the condition of the
         assets of the acquisition Companies shall have occurred since the date
         of our latest field examinations.

         Representations, Warranties, Covenants and Indemnities will be usual
         and customary for Loan Facilities of this size, type and purpose.

         Lockbox/Blocked Account: The Lender shall have dominion over the
         Borrowers cash by virtue of a Blocked Account Agreement to be arranged
         by the Lender with a Bank acceptable to the Lender. Insurance: Borrower
         will furnish the Lender with evidence of satisfactory insurance
         coverage including casualty insurance and liability insurance in form
         and in amounts acceptable to the Lender, specifying the Lender, as-loss
         payee on casualty insurance policies and as an additional insured on
         liability policies. Borrower shall maintain appropriate insurance
         coverage for the Loan Term, with a reputable underwriter satisfactory
         to the Lender.

         (k) Financial covenants: Covenants acceptable to the Lender will be
         required and may include, but not be limited to, the following:

                  (i) Borrower shall maintain a Minimum Tangible Net Worth
                  ("MTNW") (to be set forth in the loan documentation) at
                  closing and at all times prior to the Maturity Date. MTNW will
                  be defined as equity including subordinated debt, minus
                  Intangible Assets (goodwill, patents, trademarks), prepaid
                  expenses, shareholder loans and advances, tax refunds and
                  leasehold improvements, tested monthly.

                                       5
<PAGE>

                  (ii) A fixed Charge Coverage Ratio defined as at any
                  measurement date, for any period, as the ratio of: (a) EBITDA
                  for such period minus all non-financed capital, expenditures
                  made by the Borrower to (b) all payments of principal and
                  interest, including, without limitation, capitalized lease
                  obligations, taxes and dividends made in cash by the Borrower
                  during this period, tested on a rolling 12 (twelve) month
                  average.

                  (iii) A per annum capital expenditure limit. Capital
                  expenditures within such limit will be permitted so long as
                  the Borrower is in compliance with all terms of the Loan
                  Agreement.

                  (iv)A minimum EBITDA for each fiscal year with EBITDA defined
                  as earnings before interest, taxes, depreciation, and
                  amortization, tested on a 12 (twelve) month average.

         (l)      Financial Reporting: Monthly and fiscal year-end financial
                  statements for the Borrower in form and substance acceptable
                  to the Lender. The monthly statements can be internal and
                  certified by the chief financial officer and the annual
                  statements audited by an independent accounting firm and
                  certified by the chief financial officer.

         The independent accounting firm must be acceptable to the Lender. All
         financial statements must be submitted within Standard Time Frames.

         Standard Time Frames are defined as month-end statements within 30
         (thirty) days, and year-end statements with 120 (one hundred and
         twenty) days of the Borrower's financial year-end.

         Financial projections for the Borrower in form and content acceptable
         to the Lender and submitted annually to the Lender. The Lender reserves
         the right to require more frequent financial projections.

         This transaction and the events contemplated herein must close by
         February 24th, 2003 or within 45 (forty-five) days from the date of our
         credit approvals and commitment letter. Should a commitment letter not
         be requested by the Company, this transaction will close on a mutually
         acceptable date within 45 (forty five) days from the date of our Credit
         Committee approval.

9.       DEPOSITS

         (i)      We request that you deposit with us a non-refundable
                  underwriting fee of US$25,000 (Twenty Five Thousand US
                  Dollars).

         (ii)     As evidence of our mutual good faith, and in consideration of
                  our having incurred and continuing to incur certain expenses
                  in the expectation of establishing the financing arrangements
                  between us and the Company, we request that you deposit with
                  us US$85,000 (Eighty Five Thousand US Dollars) against our
                  expenses. The amount of US$45,000 (Forty Five Thousand US
                  Dollars) to be paid January 30th, 2003 and the balance of
                  US$40,000 (Forty Thousand US Dollars) to be paid by February
                  17th, 2003. These amounts, together with any other deposits at
                  any time received by us will be:

         (a)      Returned to you, less the cost of our field examinations,
                  legal fees and other expenses directly related to the loan
                  application and credit review, if our credit approval of the
                  proposed financing is not obtained;

                                       6
<PAGE>

         (b)      Retained by us, and credited to the loan account of the
                  Company, less the expenses described in paragraph (a) above,
                  if the credit is approved and booked. We will credit such
                  unused deposit against the closing fee due at closing, or
                  refund such unused deposit within 60 days of closing;

         (c)      Retained by us, as a fee in addition to expenses payable by
                  you as set forth above, if our credit approval of the proposed
                  financing is obtained and the transaction does not close
                  within 45 (forty-five) days from the date of such approval,
                  whether as a result of your election not to do business with
                  us or a failure to fulfill any of the conditions of the
                  proposed financing as approved by us; and

         (d)      Retained by us, as a fee in addition to expenses payable by
                  you as set forth above, if at any time during the loan and
                  credit review, you intentionally mislead us or intentionally
                  fail to disclose material information which, if disclosed,
                  would have had a material adverse impact on the loan approval.

The terms and conditions described in this proposal letter are intended as an
outline only and this proposal letter does not purport to include or summarize
all of the terms, conditions, covenants and other provisions, which will be
contained on the loan documents.

This letter is delivered to you on the condition that its existence and its
contents will not be disclosed by you or the Company without our prior written
approval except (1) as may be required to be disclosed in any legal proceedings
or as may otherwise be required by law, and (2) on a confidential and "need to
know" basis, to your directors, officers, employees, advisors and agents.

Unless accepted by you and as so accepted, received by us by the close of
business on Tuesday January 14th, 2003 with the underwriting deposit referred to
in paragraph 9.(i) above, this proposal shall expire at such a time.

This letter is solely for your benefit and is not to be relied upon by any third
party.

We look forward to continuing to work with you and your associates in this
transaction and your acceptance represents our mutual intention to proceed on
this transaction.

Very truly yours,

INVESTORS CORPORATION

/s/ J. Cathcart
By:  J. Cathcart

Accepted this 11th day of January, 2003.

/s/ Armand Dauplaise
By:  Armand Dauplaise

Title:   President & CEO

                                       7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00056-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00056-of-00352.parquet"}]]